Evidence map›Paper›PMID 42856971›Full record

ReviewLiver research (Beijing, China)2026

Context-dependent duality of senescent cells in liver fibrosis.

Yuqi Gu, Linjing Zhan, Yaping Di, Haipeng Wu, Tiejun Zhao, Fei Zhang, Qirou Wu

Abstract readReview
In one paragraph

Review in Liver research (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuqi GuSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Linjing ZhanSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Yaping DiSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Haipeng WuSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Tiejun ZhaoSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.
Fei ZhangInstitute of Intelligent Medicine, ZJU Hangzhou Global Scientific and Technological Innovation Center, Hangzhou, Zhejiang, China.
Qirou WuSchool of Medicine, Hangzhou City University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver fibrosis, marked by excessive deposition of extracellular matrix (ECM), is a critical precursor to cirrhosis, liver failure, and hepatocellular carcinoma. Accumulating evidence highlights that cellular senescence, characterized by stable cell-cycle arrest and senescence-associated secretory phenotypes (SASPs), is a key regulator of the fibrotic process. This review systematically dissects the context-dependent roles of senescent cells in liver fibrosis, with a focus on hepatocytes, hepatic stellate cells (HSCs), liver sinusoidal endothelial cells (LSECs), Kupffer cells, and natural killer (NK) cells. Distinct populations of senescent cells emerge sequentially during different stages of fibrosis, exhibiting divergent kinetics and functional effects. The SASP, a dynamic cocktail composed of cytokines, chemokines, and proteases, remodels the intrahepatic microenvironment through immune cell recruitment, regulation of cell function, and modulation of ECM turnover. These effects vary depending on their molecular composition and disease context. Furthermore, we discuss emerging senescence-targeted therapeutic strategies to restore liver homeostasis. In-depth understanding of the cell-type and stage-specific roles of senescence in fibrosis provides a molecular foundation for translating senescence-targeted strategies into clinical precision antifibrotic therapies.

Indexed as

Antifibrotic therapyCellular senescenceHepatic stellate cell (HSC)Liver fibrosisSenescence-associated secretory phenotype (SASP)

Identifiers

PMID42856971
PMCPMC13649512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.